bleeding disorders

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, July 14, 2026 Hemab Therapeutics presented new clinical and preclinical data at the International...

PARAMUS, N.J. | July 8, 2026 Octapharma USA has announced that the U.S. Food and Drug Administration (FDA) has...

SOUTH SAN FRANCISCO, Calif., June 26, 2026 Star Therapeutics announced it will present complete safety and efficacy data from...

NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...

LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...

WILMINGTON, Delaware, USA – June 8, 2026 Incyte Corporation has announced a definitive agreement to acquire Vega Therapeutics, a...

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2025 — Star Therapeutics announced it has closed an oversubscribed $125 million Series...